Lung cancer has been the leading cause of cancer-related mortality in China in recent
decades. Positron emission tomography-computer tomography (PET/CT) has been …

Over the past several years, positron emission tomography (PET) has become a clinically
useful, noninvasive study which complements conventional imaging (chest radiographs …

Positron emission tomography (PET) with [18F] fluorodeoxyglucose (FDG) has been
established as a useful tool in the management of patients with non-small cell lung cancer …

Positron emission tomography imaging with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18 F-
FDG) has been established as a significant molecular imaging technique in the …

Positron emission tomography (PET) is emerging as a powerful tool that complements
conventional radiologic assessment (chest radiographs, CT scans, MR imaging) of thoracic …

Positron emission tomography (PET) has been studied for a variety of indications in patients
with known or suspected non–small-cell lung cancer (NSCLC). This article discusses the …

Positron emission tomography (PET) using 2-(18F)-flouro-2-deoxy-D-glucose (FDG) has
emerged as a useful tool in the clinical work-up of lung cancer. This review article provides …

With a 5-year overall survival of approximately 20%, lung cancer has always been the
number one cancer-specific killer all over the world. As a fusion of positron emission …

Recent advances in positron emission tomography (PET) with 2-deoxy-2-fluoro [F-18]-d-
glucose (FDG) has enabled not only the diagnosis and staging of lung cancer but also the …

▪ Abstract Whole-body positron emission tomography (PET) imaging with 18F deoxyglucose
(FDG) is a molecular imaging modality that detects metabolic alterations in tumor cells that …